We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+25.54%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.9M
AUM Growth
–
Cap. Flow
+$85.6M
Cap. Flow %
91.25%
Top 10 Hldgs %
18.41%
Holding
648
New
647
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$6.31M
2
AAPL icon
Apple
AAPL
+$1.23M
3
META icon
Meta Platforms (Facebook)
META
+$1.1M
4
HD icon
Home Depot
HD
+$1.08M
5
ITW icon
Illinois Tool Works
ITW
+$1.05M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 37.67%
2 Consumer Discretionary 19.1%
3 Industrials 8.58%
4 Communication Services 7.27%
5 Consumer Staples 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSE
426
DELISTED
Trinseo
TSE
$3K ﹤0.01%
+67
New +$2.55K
TSLX icon
427
Sixth Street Specialty
TSLX
$1.79B
$3K ﹤0.01%
+169
New +$3.21K
VST icon
428
Vistra
VST
$49.2B
$3K ﹤0.01%
+165
New +$3.07K
WEN icon
429
Wendy's
WEN
$1.65B
$3K ﹤0.01%
+137
New +$3.12K
WING icon
430
Wingstop
WING
$3.05B
$3K ﹤0.01%
+29
New +$3.79K
XNCR icon
431
Xencor
XNCR
$1.72B
$3K ﹤0.01%
+70
New +$2.9K
SCPL
432
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$3K ﹤0.01%
+240
New +$3.49K
AJRD
433
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$3K ﹤0.01%
+63
New +$2.53K
TMX
434
DELISTED
Terminix Global Holdings, Inc.
TMX
$3K ﹤0.01%
+74
New +$3.57K
GBT
435
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3K ﹤0.01%
+80
New +$3.94K
CHNG
436
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$3K ﹤0.01%
+183
New +$3.01K
MNDT
437
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3K ﹤0.01%
+141
New +$2.17K
ZNGA
438
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$3K ﹤0.01%
+323
New +$2.91K
DISCK
439
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3K ﹤0.01%
+147
New +$3.22K
PFPT
440
DELISTED
Proofpoint, Inc.
PFPT
$3K ﹤0.01%
+22
New +$2.41K
ALXN
441
DELISTED
Alexion Pharmaceuticals
ALXN
$3K ﹤0.01%
+21
New +$2.7K
CIT
442
DELISTED
CIT Group Inc.
CIT
$3K ﹤0.01%
+100
New +$3.15K
AES icon
443
AES
AES
$10.5B
$2K ﹤0.01%
+115
New +$2.39K
APD icon
444
Air Products & Chemicals
APD
$67.7B
$2K ﹤0.01%
+9
New +$2.54K
BG icon
445
Bunge Global
BG
$21.5B
$2K ﹤0.01%
+40
New +$2.33K
BX icon
446
Blackstone
BX
$110B
$2K ﹤0.01%
+34
New +$1.98K
CAT icon
447
Caterpillar
CAT
$393B
$2K ﹤0.01%
+14
New +$2.37K
CCK icon
448
Crown Holdings
CCK
$13.1B
$2K ﹤0.01%
+26
New +$2.39K
CELH icon
449
Celsius Holdings
CELH
$6.99B
$2K ﹤0.01%
+120
New +$1.2K
CHWY icon
450
Chewy
CHWY
$9.15B
$2K ﹤0.01%
+27
New +$1.97K
16 17
18
19 20

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Alpha DNA Investment Management, which disclosed 648 positions worth $93.9M. Its ten largest holdings account for 18% of the portfolio.

Its largest position is State Street SPDR Portfolio S&P 500 Growth ETF: 120,151 shares worth $6.64M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, followed by Consumer Discretionary and Industrials.

  • Alpha DNA Investment Management's largest Q4 2020 buy was State Street SPDR Portfolio S&P 500 Growth ETF: 120,151 shares worth $6.64M.
  • Alpha DNA Investment Management's ten largest holdings make up 18% of its $93.9M portfolio in Q4 2020.
  • Alpha DNA Investment Management disclosed 648 positions in Q4 2020, its first 13F filing on record.

Based on Alpha DNA Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.